Long-term Results of Pulmonary Vein Antrum Isolation in Patients with Atrial Fibrillation: an Analysis in Regards to Substrates and Pulmonary Vein Reconnections
Overview
Physiology
Authors
Affiliations
Aims: To examine the impact of left atrial (LA) low-voltage zones (LVZs) on atrial fibrillation (AF) recurrence after pulmonary vein antrum isolation (PVAI) without LA substrate modification.
Methods And Results: Seventy-six patients with AF (paroxysmal/persistent 65/11) were prospectively enroled. Left atrial voltage maps were constructed during sinus rhythm using NavX to identify LVZs (<0.5 mV), and PVAI without any LA substrate modification was performed using an open-irrigation catheter. After PVAI, 20 mg of adenosine triphosphate (ATP) was injected. Adenosine triphosphate-induced PV reconnections were eliminated by touch-up ablation when unmasked. Voltage maps revealed LVZs in 24 patients (32%) and no LVZs in 52 (68%). During 24 ± 7 months of follow-up, 15 patients (63%) with LVZs and 10 (19%) without had AF recurrences off antiarrhythmic drugs (log-rank P < 0.001). A multivariate logistic regression analysis revealed that LVZ areas [odds ratio (OR): 1.12 per 1 cm(2), 95% confidence interval (CI): 1.04-1.23, P = 0.001] and ATP-induced reconnection (OR: 2.08, 95% CI: 1.01-4.91, P = 0.046) were significant predictors of recurrence. In those with LVZs, the LVZ area was strongly correlated with the LA body volume (r = 0.81, P < 0.001) and a unique predictor of recurrence (OR: 1.17 per 1 cm(2), 95% CI: 1.01-1.55, P = 0.031), while in those without an LVZ, ATP-induced PV reconnection was a unique predictor (OR: 3.24, 95% CI: 1.15-15.39, P = 0.025).
Conclusion: The LVZ area was an independent predictor of recurrence after PVAI without any LA substrate modification. Adenosine triphosphate-induced PV reconnection was also an independent predictor, especially in those without LVZs.
Huttelmaier M, Gabel A, Herting J, Vogel M, Stork S, Frantz S J Interv Card Electrophysiol. 2025; .
PMID: 39899140 DOI: 10.1007/s10840-025-02001-2.
Early Echocardiographic Predictors for Atrial Fibrillation Propensity: The Left Atrium Oracle.
Matei L, Popescu R, Popescu A, Balanescu S Rev Cardiovasc Med. 2024; 23(6):205.
PMID: 39077189 PMC: 11273662. DOI: 10.31083/j.rcm2306205.
Li M, Liu X, Zhang Y, Huang W, Hou B, Huang S BMC Cardiovasc Disord. 2024; 24(1):118.
PMID: 38378465 PMC: 10877843. DOI: 10.1186/s12872-024-03787-1.
Sekihara T, Oka T, Ozu K, Sakata Y J Arrhythm. 2024; 40(1):90-99.
PMID: 38333386 PMC: 10848603. DOI: 10.1002/joa3.12971.
Sonoda K, Fukushima T, Takei A, Otsuka K, Hata S, Shinboku H J Interv Card Electrophysiol. 2024; 67(5):1199-1210.
PMID: 38321306 PMC: 11288992. DOI: 10.1007/s10840-024-01760-8.